Announce Date | 02/06/2025 |
EPS Normalized Actual | $0.23 (Beat by $0.44) |
EPS GAAP Actual | $0.23 (Beat by $0.44) |
Revenue Actual | $0.244895B |
Revenue Surprise | Beat by $244.895M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2029 | 3.9 | 9.17 | 3.52247 | 4.20727 | 2 |
Jun 2028 | -0.91 | -39.29 | -0.96843 | -0.82166 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.25 | 0.25 | 0.244895B | 23.09% | 244.9M |
FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 0.184339B | 20.83% | 184.34M |
FQ2 2024 (Jun 2024) | -0.15 | -0.15 | -0.989207B | 145.07% | -989.21M |
FQ1 2024 (Mar 2024) | -0.43 | -0.43 | 0.159292B | 25.29% | 159.29M |
FQ4 2023 (Dec 2023) | -0.0005 | -0.0005 | 0.188357B | -112.13% | 188.36M |
FQ3 2023 (Sep 2023) | -0.57 | -0.57 | 0.14595B | -147.77% | 145.95M |
FQ2 2023 (Jun 2023) | 0 | 0 | 0.445825B | 18.32% | 445.83M |
FQ1 2023 (Mar 2023) | -0.69 | -0.69 | 0.119013B | 100% | 119.01M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Mar 2029) | 0.87 | -- | 0.79957 | 0.97799 | 1 |
FQ4 2028 (Dec 2028) | 1.04 | -- | 0.95581 | 1.16909 | 2 |
FQ3 2028 (Jul 2028) | -0.2 | -- | -0.20826 | -0.18805 | 6 |
FQ1 2028 (Mar 2028) | -0.26 | -- | -0.27649 | -0.2447 | 3 |
FQ4 2027 (Oct 2027) | -0.06 | -- | -0.06247826 | -0.0564154 | 2 |
FQ3 2027 (Jul 2027) | -0.26 | -- | -0.27074 | -0.24447 | 2 |
FQ1 2027 (Mar 2027) | -0.3 | -- | -0.31902 | -0.28235 | 2 |
FQ4 2026 (Oct 2026) | -0.18 | -- | -0.18743 | -0.16925 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2029 (Mar 2029) | 4.01B | -- | 3.76B | 4.39B | 9 |
FQ4 2028 (Dec 2028) | 3.64B | -- | 3.41B | 3.99B | 8 |
FQ3 2028 (Jul 2028) | 1.11B | -- | 1.06B | 1.15B | 5 |
FQ1 2028 (Mar 2028) | 1B | -- | 0.96B | 1.05B | 3 |
FQ4 2027 (Oct 2027) | 0.99B | -- | 0.94B | 1.02B | 4 |
FQ3 2027 (Jul 2027) | 0.99B | -- | 0.94B | 1.02B | 6 |
FQ1 2027 (Mar 2027) | 0.88B | -- | 0.84B | 0.93B | 8 |
FQ4 2026 (Oct 2026) | 0.87B | -- | 0.83B | 0.9B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.25 | 0.25 | 100% | |
FQ3 2024 (Sep 2024) | -0.31 | -0.31 | 100% | |
FQ2 2024 (Jun 2024) | -0.15 | -0.15 | 100% | |
FQ1 2024 (Mar 2024) | -0.43 | -0.43 | 100% | |
FQ4 2023 (Dec 2023) | -0.0005 | -0.0005 | 100% | |
FQ3 2023 (Sep 2023) | -0.57 | -0.57 | 100% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% | |
FQ1 2023 (Mar 2023) | -0.69 | -0.69 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.24B | $244.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.18B | $184.34M | 100% |
FQ2 2024 (Jun 2024) | $0B | $-0.99B | $-989.21M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.16B | $159.29M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.19B | $188.36M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.15B | $145.95M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.45B | $445.83M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.12B | $119.01M | 100% |